Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
about
Calcium-regulated transcriptional pathways in the normal and pathologic heartStructure of human carnitine acetyltransferase. Molecular basis for fatty acyl transferInsulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation.Acetyl-l-carnitine and oxfenicine on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar ratsPerhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicityThe PPARalpha-PGC-1alpha Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium.Regulation of the sarcoplasmic reticulum Ca2+-ATPase expression in the hypertrophic and failing heart.Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease.The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica reduces obesity via skeletal muscle AMPK and PPARα.Tedisamil attenuates foetal transformation of myosin in the hypertrophied rat myocardium.A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.A grape polyphenol extract modulates muscle membrane fatty acid composition and lipid metabolism in high-fat--high-sucrose diet-fed rats.
P2860
Q27022874-8191B293-EB38-4177-B8D1-A67B2CE51FEEQ27640412-82839814-A3E4-407B-821B-5C3DD221C08BQ34435166-0B52C8BF-B6C5-48E3-B8C8-D152E3AEE4E4Q34905231-01BE0454-52B0-47F0-9F6A-635E82000A4AQ36165683-31FF19F6-08EB-42AF-9976-240C958C56D7Q36359620-E96B5B65-A82E-4DA0-B524-EEC652ACAD4FQ36426768-A2E2E72E-A171-40D0-B048-96A8BCD62E66Q36562746-3D3ABDA5-90A3-4F13-8BEF-BBA5A5BB2348Q37024621-5DD485D5-DC59-4695-B36A-B9A9AFEBA5C6Q39435401-B54E1436-0928-4FBF-99AE-17011C977B2CQ43262076-73D9D88F-8F36-42E0-90CB-48BBAA05D5F1Q46753306-28F5C119-E9B6-4739-88E1-15AFF7D01C13Q50537339-54A41456-B690-4A72-98F9-B2EA3763B6EA
P2860
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
@ast
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
@en
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
@nl
type
label
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
@ast
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
@en
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
@nl
prefLabel
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
@ast
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
@en
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
@nl
P2860
P1476
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
@en
P2093
Angel Zarain-Herzberg
Heinz Rupp
P2860
P304
P356
10.1517/13543784.11.3.345
P407
P577
2002-03-01T00:00:00Z